|
Delayed
Deutsche Boerse AG
02:03:52 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 0.0328 EUR | -3.81% |
|
+15.90% | +72.63% |
| 09-03 | Xoma launches project for biological production of silicon for chips | FW |
| 09-02 | Xoma secures a SEK 5m credit facility | FW |
| Fiscal Period: December | 2022 (SEK) | 2023 (SEK) | 2024 (SEK) | 2025 (SEK) |
|---|---|---|---|---|
Profitability | ||||
Return on Assets | - | -41.68 | -60.85 | -55.65 |
Return on Total Capital | - | -67.93 | -68.91 | -61.68 |
Return On Equity % | - | -108.68 | -146.15 | -100.79 |
Return on Common Equity | - | -108.68 | -146.15 | -100.79 |
Margin Analysis | ||||
Gross Profit Margin % | - | 100 | 100 | 96.27 |
SG&A Margin | - | 1.43K | 1.27K | 700.08 |
EBITDA Margin % | - | -1.33K | -1.17K | -603.81 |
EBITA Margin % | - | -1.43K | -1.22K | -613.25 |
EBIT Margin % | - | -1.43K | -1.22K | -613.25 |
Income From Continuing Operations Margin % | - | -1.43K | -1.22K | -613.41 |
Net Income Margin % | - | -1.43K | -1.22K | -613.41 |
Net Avail. For Common Margin % | - | -1.43K | -1.22K | -613.41 |
Normalized Net Income Margin | - | -893.74 | -760.91 | -383.38 |
Levered Free Cash Flow Margin | - | - | -783.51 | -440.61 |
Unlevered Free Cash Flow Margin | - | - | -782.65 | -440.51 |
Asset Turnover | ||||
Asset Turnover | - | 0.05 | 0.08 | 0.15 |
Fixed Assets Turnover | - | 0.09 | 0.17 | 1.05 |
Short Term Liquidity | ||||
Current Ratio | 5.94 | 10.59 | 3.55 | 9.98 |
Quick Ratio | 5.79 | 10.49 | 3.25 | 9.91 |
Operating Cash Flow to Current Liabilities | - | - | -4.25 | -6.34 |
Average Days Payable Outstanding | - | - | - | 2.07K |
Long Term Solvency | ||||
Total Debt/Equity | - | - | 12.41 | - |
Total Debt / Total Capital | - | - | 11.04 | - |
LT Debt/Equity | - | - | 12.41 | - |
Long-Term Debt / Total Capital | - | - | 11.04 | - |
Total Liabilities / Total Assets | 31.42 | 47.26 | 25.7 | 8.09 |
EBIT / Interest Expense | -7.07K | -15.88K | -886.81 | -3.67K |
EBITDA / Interest Expense | -6.54K | -14.76K | -853.94 | -3.62K |
(EBITDA - Capex) / Interest Expense | -6.54K | -14.76K | -853.94 | -3.65K |
Total Debt / EBITDA | - | - | -0.13 | - |
Net Debt / EBITDA | 0.97 | 0.45 | 0.5 | 1.41 |
Total Debt / (EBITDA - Capex) | - | - | -0.13 | - |
Net Debt / (EBITDA - Capex) | 0.97 | 0.45 | 0.5 | 1.39 |
Growth Over Prior Year | ||||
Total Revenues, 1 Yr. Growth % | - | - | 121.9 | 483.05 |
Gross Profit, 1 Yr. Growth % | - | - | 121.9 | 461.28 |
EBITDA, 1 Yr. Growth % | - | 7.48 | 95.37 | 200.63 |
EBITA, 1 Yr. Growth % | - | 6.92 | 88.7 | 194.01 |
EBIT, 1 Yr. Growth % | - | 6.92 | 88.7 | 194.01 |
Earnings From Cont. Operations, 1 Yr. Growth % | - | 6.9 | 88.92 | 193.76 |
Net Income, 1 Yr. Growth % | - | 6.9 | 88.92 | 193.76 |
Normalized Net Income, 1 Yr. Growth % | - | 6.9 | 88.92 | 193.76 |
Diluted EPS Before Extra, 1 Yr. Growth % | - | - | - | -72.77 |
Net Property, Plant and Equip., 1 Yr. Growth % | - | 45.96 | -7.41 | -3.46 |
Total Assets, 1 Yr. Growth % | - | -16.02 | 83.17 | 296.96 |
Tangible Book Value, 1 Yr. Growth % | - | -35.41 | 156.33 | 393.61 |
Common Equity, 1 Yr. Growth % | - | -35.41 | 158.01 | 391.05 |
Cash From Operations, 1 Yr. Growth % | - | - | 91.47 | 190.71 |
Levered Free Cash Flow, 1 Yr. Growth % | - | - | 33.62 | 227.88 |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | - | 33.48 | 228.17 |
Compound Annual Growth Rate Over Two Years | ||||
Total Revenues, 2 Yr. CAGR % | - | - | - | 259.69 |
Gross Profit, 2 Yr. CAGR % | - | - | - | 252.91 |
EBITDA, 2 Yr. CAGR % | - | - | 44.91 | 142.35 |
EBITA, 2 Yr. CAGR % | - | - | 42.04 | 135.54 |
EBIT, 2 Yr. CAGR % | - | - | 42.04 | 135.54 |
Earnings From Cont. Operations, 2 Yr. CAGR % | - | - | 42.11 | 135.58 |
Net Income, 2 Yr. CAGR % | - | - | 42.11 | 135.58 |
Normalized Net Income, 2 Yr. CAGR % | - | - | 42.11 | 135.58 |
Net Property, Plant and Equip., 2 Yr. CAGR % | - | - | 16.25 | -5.46 |
Total Assets, 2 Yr. CAGR % | - | - | 24.02 | 169.65 |
Tangible Book Value, 2 Yr. CAGR % | - | - | 28.67 | 255.71 |
Common Equity, 2 Yr. CAGR % | - | - | 29.09 | 255.94 |
Cash From Operations, 2 Yr. CAGR % | - | - | - | 135.93 |
Capital Expenditures, 2 Yr. CAGR % | - | - | - | -61.27 |
Levered Free Cash Flow, 2 Yr. CAGR % | - | - | - | 109.31 |
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | - | - | 109.29 |
Compound Annual Growth Rate Over Three Years | ||||
EBITDA, 3 Yr. CAGR % | - | - | - | 84.82 |
EBITA, 3 Yr. CAGR % | - | - | - | 81.02 |
EBIT, 3 Yr. CAGR % | - | - | - | 81.02 |
Earnings From Cont. Operations, 3 Yr. CAGR % | - | - | - | 81.03 |
Net Income, 3 Yr. CAGR % | - | - | - | 81.03 |
Normalized Net Income, 3 Yr. CAGR % | - | - | - | 81.03 |
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | - | 9.27 |
Total Assets, 3 Yr. CAGR % | - | - | - | 82.78 |
Tangible Book Value, 3 Yr. CAGR % | - | - | - | 101.42 |
Common Equity, 3 Yr. CAGR % | - | - | - | 101.51 |
- Stock Market
- Stocks
- XOM B Stock
- QM8 Stock
- Financials Xoma AB
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















